Literature DB >> 16156680

Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause.

Maria Cristina G Passarelli1, Wilson Jacob-Filho, Albert Figueras.   

Abstract

OBJECTIVE: Adverse drug reactions (ADRs) represent a major public health problem in the aged. In order to better evaluate this problem in Brazil, this study was designed to assess the prevalence of ADRs in an elderly hospitalised population, identify the most common ADRs and the principal medications involved, evaluate the appropriateness of use of these drugs in elderly people and determine the risk factors implicated in the appearance of such ADRs.
METHODS: The study population was comprised of 186 elderly patients (> or =60 years of age) admitted to the internal medicine service of a teaching hospital. The patients were assessed by a single observer using an intensive drug surveillance method to identify and report ADRs. The degree of probability for each adverse reaction was determined using the Naranjo algorithm.
RESULTS: The mean (+/- SD) age of the patients studied was 73.6 +/- 9.1 years. Up to 115 patients (61.8%) of the study population presented at least one ADR. A total of 199 ADRs were found, at an average of 1.7 per patient. The ADRs appeared during hospitalisation in 46.2% of the study population, were present at the time of the admission but did not cause hospitalisation in 17.2% of patients, and were the cause of admission in 11.3% of patients. The most frequent ADR that caused hospitalisation was digitalis toxicity (22.7% of such ADRs). Hypokalaemia as a result of diuretics was the most prevalent ADR both during hospitalisation (11.8%) and at the time of admission without being the cause (12.1%). Captopril was the most frequently prescribed drug (138 prescriptions), and led to an ADR in 18.1% of patients who received the drug. Almost a quarter of the patients presenting an ADR were prescribed drugs considered inappropriate for the elderly. By means of a multiple logistic regression model, the following were considered to be significant risk factors for the appearance of ADRs: number of diagnoses (odds ratio [OR] 1.40; 95% CI 1.06, 1.86), number of drugs (OR 1.07; 95% CI 1.01, 1.13) and use of drug that is inappropriate for the elderly (OR 2.32; 95% CI 1.17, 4.59). DISCUSSION: The main contribution of the present study was identification of use of drugs that are considered inappropriate for elderly populations as a major risk factor for presenting an ADR. This finding is useful for continuous education programmes, therapeutic committees and policy makers, because adverse effects complicate the course of diseases in aged patients, cause hospitalisation and/or require the prescription of additional drugs. In addition to contributing to a reduction in healthcare costs, continuous efforts to promote rational drug use could also benefit elderly patients by preventing some avoidable drug toxicity.
CONCLUSION: A significant prevalence of ADRs was found among hospitalised elderly people. The risk factors associated with ADRs in this population included use of drugs considered to be inappropriate for that population, number of previous diagnoses and number of administered drugs. More appropriate drug prescription could avoid part of this burden of disease by minimising preventable ADRs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16156680     DOI: 10.2165/00002512-200522090-00005

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  50 in total

Review 1.  Pharmacovigilance in perspective.

Authors:  R H Meyboom; A C Egberts; F W Gribnau; Y A Hekster
Journal:  Drug Saf       Date:  1999-12       Impact factor: 5.606

2.  Characterization of drug-related problems in elderly patients on admission to a medical ward.

Authors:  B J Courtman; S B Stallings
Journal:  Can J Hosp Pharm       Date:  1995-06

3.  Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.

Authors:  Donna M Fick; James W Cooper; William E Wade; Jennifer L Waller; J Ross Maclean; Mark H Beers
Journal:  Arch Intern Med       Date:  2003 Dec 8-22

4.  Drug use and adverse drug reactions prior to and during hospitalization.

Authors:  F E May; S Fuller; R B Stewart
Journal:  J Am Pharm Assoc       Date:  1977-09       Impact factor: 2.217

Review 5.  Prescribing for the elderly. Part I: Sensitivity of the elderly to adverse drug reactions.

Authors:  L Nolan; K O'Malley
Journal:  J Am Geriatr Soc       Date:  1988-02       Impact factor: 5.562

Review 6.  Preventable drug reactions--causes and cures.

Authors:  K L Melmon
Journal:  N Engl J Med       Date:  1971-06-17       Impact factor: 91.245

7.  Contribution of adverse drug reactions to hospital admission of older patients.

Authors:  C K Mannesse; F H Derkx; M A de Ridder; A J Man in 't Veld; T J van der Cammen
Journal:  Age Ageing       Date:  2000-01       Impact factor: 10.668

8.  Is age an independent risk factor of adverse drug reactions in hospitalized medical patients?

Authors:  P Carbonin; M Pahor; R Bernabei; A Sgadari
Journal:  J Am Geriatr Soc       Date:  1991-11       Impact factor: 5.562

9.  Frequency, severity and risk factors for adverse drug reactions in adult out-patients: a prospective study.

Authors:  T A Hutchinson; K M Flegel; M S Kramer; D G Leduc; H H Kong
Journal:  J Chronic Dis       Date:  1986

Review 10.  Important drug-drug interactions in the elderly.

Authors:  R M Seymour; P A Routledge
Journal:  Drugs Aging       Date:  1998-06       Impact factor: 4.271

View more
  102 in total

Review 1.  American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2012-02-29       Impact factor: 5.562

2.  Preventable and non-preventable adverse drug events in hospitalized patients: a prospective chart review in the Netherlands.

Authors:  Aileen B Dequito; Peter G M Mol; Jasperien E van Doormaal; Rianne J Zaal; Patricia M L A van den Bemt; Flora M Haaijer-Ruskamp; Jos G W Kosterink
Journal:  Drug Saf       Date:  2011-11-01       Impact factor: 5.606

Review 3.  Polypharmacy in older adults with cancer.

Authors:  Ronald J Maggiore; Cary P Gross; Arti Hurria
Journal:  Oncologist       Date:  2010-04-24

Review 4.  Comparison of published explicit criteria for potentially inappropriate medications in older adults.

Authors:  Chirn-Bin Chang; Ding-Cheng Chan
Journal:  Drugs Aging       Date:  2010-12-01       Impact factor: 3.923

5.  Facility-level variation in potentially inappropriate prescribing for older veterans.

Authors:  Walid F Gellad; Chester B Good; Megan E Amuan; Zachary A Marcum; Joseph T Hanlon; Mary Jo V Pugh
Journal:  J Am Geriatr Soc       Date:  2012-06-21       Impact factor: 5.562

Review 6.  [Diuretics-related complications in elderly patients].

Authors:  Ronald Otto; Regina E Roller; Bernhard Iglseder; Peter Dovjak; Monika Lechleitner; Ulrike Sommeregger; Ursula Benvenuti-Falger; Birgit Böhmdorfer; Markus Gosch
Journal:  Wien Med Wochenschr       Date:  2010-06

7.  Potentially Inappropriate Medication and Health Care Outcomes: An Instrumental Variable Approach.

Authors:  Chi-Chen Chen; Shou-Hsia Cheng
Journal:  Health Serv Res       Date:  2015-11-25       Impact factor: 3.402

8.  Potentially inappropriate medicines in elderly hospitalised patients according to the EU(7)-PIM list, STOPP version 2 criteria and comprehensive protocol.

Authors:  Iva Mucalo; Maja Ortner Hadžiabdić; Andrea Brajković; Sonja Lukić; Patricia Marić; Ivana Marinović; Vesna Bačić-Vrca
Journal:  Eur J Clin Pharmacol       Date:  2017-04-12       Impact factor: 2.953

Review 9.  The clinical implications of ageing for rational drug therapy.

Authors:  Shaojun Shi; Klaus Mörike; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2008-01-05       Impact factor: 2.953

10.  Repeat adverse drug reactions causing hospitalization in older Australians: a population-based longitudinal study 1980-2003.

Authors:  Min Zhang; C D'Arcy J Holman; David B Preen; Kate Brameld
Journal:  Br J Clin Pharmacol       Date:  2007-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.